rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Julie So-Young Kim

President and CEO

Company insider

Files Form 4 as: President and CEO, Takeda Pharmaceutical Company.

Every Form 4 they filed

In numbers

Trades disclosed
14
Buys
0
Sells
1
Bought
$0
Sold
$3.0M
Companies
1
Companies where not an officer
0
First trade
27 Apr 2026
Last trade
10 Aug 2026
Last filed
12 Aug 2026

Companies traded

Where they are an officer
TAK Takeda Pharmaceutical CompanyDirector, Officer · Pharmaceuticals · last 10 Aug 20260 buys · 1 sell

Activity over time

1 Aug – 1 Oct
101 Aug1 Sep1 Oct

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
10 Aug 2026filed 12 Aug 2026TAK Takeda Pharmaceutical CompanyPharmaceuticalsSEC FORM 4 Sold$1.5M89,090 at $17.10filing
10 Aug 2026filed 12 Aug 2026TAK Takeda Pharmaceutical CompanyPharmaceuticalsSEC FORM 4 Sold$1.5M89,090 at $17.10filing
1 Jul 2026filed 6 Jul 2026TAK Takeda Pharmaceutical CompanyPharmaceuticalsSEC FORM 4 Code A—50,434 at $0.00filing
1 Jul 2026filed 6 Jul 2026TAK Takeda Pharmaceutical CompanyPharmaceuticalsSEC FORM 4 Code A—22,800 at $0.00filing
1 Jul 2026filed 6 Jul 2026TAK Takeda Pharmaceutical Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A—7,741 at $0.00filing
1 Jul 2026filed 6 Jul 2026TAK Takeda Pharmaceutical Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A—7,741 at $0.00filing
1 Jul 2026filed 6 Jul 2026TAK Takeda Pharmaceutical Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A—7,741 at $0.00filing
1 Jul 2026filed 6 Jul 2026TAK Takeda Pharmaceutical Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A—7,743 at $0.00filing
1 Jul 2026filed 6 Jul 2026TAK Takeda Pharmaceutical Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A—7,741 at $0.00filing
1 Jul 2026filed 6 Jul 2026TAK Takeda Pharmaceutical Companyoption or derivative · PharmaceuticalsSEC FORM 4 Code A—7,743 at $0.00filing
1 Jul 2026filed 6 Jul 2026TAK Takeda Pharmaceutical CompanyPharmaceuticalsSEC FORM 4 Code A—50,434 at $0.00filing
1 Jul 2026filed 6 Jul 2026TAK Takeda Pharmaceutical CompanyPharmaceuticalsSEC FORM 4 Code A—22,800 at $0.00filing
27 Apr 2026filed 28 Apr 2026TAK Takeda Pharmaceutical CompanyPharmaceuticalsSEC FORM 4 Code A—105,416 at $0.00filing
27 Apr 2026filed 28 Apr 2026TAK Takeda Pharmaceutical CompanyPharmaceuticalsSEC FORM 4 Code A—105,416 at $0.00filing

News

Addex Therapeutics (NASDAQ:ADXN) & Takeda Pharmaceutical (NYSE:TAK) Head-To-Head AnalysisTAK · tickerreport.com · 26 Oct 2026

0 headlines in the last 90 days name Julie So-Young Kim; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Lauren Rusckowski DupreyChief Transformation Officer · Chief Transformation Officer at Takeda Pharmaceutical Co, filing Form 4 there in the last year
Andrew Stewart PlumpPresident, R&D · President, R&D at Takeda Pharmaceutical Co, filing Form 4 there in the last year
Nicola Deidre Petal GreenwayChief Human Resources Officer · Chief Human Resources Officer at Takeda Pharmaceutical Co, filing Form 4 there in the last year
Rhonda Janice PachecoPresident, U.S. Business Unit · President, U.S. Business Unit at Takeda Pharmaceutical Co, filing Form 4 there in the last year
Natalie Anne Marie FurneyGlobal General Counsel · Global General Counsel at Takeda Pharmaceutical Co, filing Form 4 there in the last year
Elaine Mary ShannonPres., Global Supply & Quality · Also traded TAK in the last 90 days
Agosti Marcello PignagnoliHead, Strat. & Port. Dev · Also traded TAK in the last 90 days
Awny Samaan Botros FarajallahChief Medical Officer · Also traded TAK in the last 90 days